/

Other

/

Daiichi Sankyo, Inc

Daiichi Sankyo, Inc

Daiichi Sankyo, Inc

Verified Nov 2026

Other

·

United States flag

Bernards, New Jersey

·

Since 2005

Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.

Daiichi Sankyo, Inc

Verified Nov 2026

AT A GLANCE

Founded

2005

Headquarters

United States flag

Bernards, New Jersey

Employees

10,000-50,000

Ownership

Daiichi Sankyo, Inc at a glance

Revenue

$10B+

Est. band

Employees

10,000-50,000

Founded

2005

Headquarters

Bernards, New Jersey

Certifications

ISO 14001 · ISO 45001

Import activity

42

Industries

Automotive

Electric Vehicles

Medical

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

42

Named foreign suppliers

37

Top origins

Singapore · Republic of Korea

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Daiichi Sankyo, Inc.

What this tells a buyer

The company received 42 recorded shipments, predominantly sourced from Japan, with suppliers including Mr Go Saito (5 shipments) and multiple other Japanese partners, alongside imports from Singapore and the Republic of Korea.

Daiichi Sankyo holds ISO 14001 and ISO 45001 certifications and maintains a clinical development pipeline in oncology supported by partnerships with AstraZeneca and other major pharmaceutical firms.

The company announced $1.9 billion in capital investment across production lines in China and the United States as of early 2026, and established a new Toronto headquarters to support oncology innovation and expansion in the Asia-Pacific region.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

21 years in operation (founded 2005).

42 US import shipments on record.

Holds ISO 14001, ISO 45001 certification(s) per public sources.

Overview

Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.

At a glance

Attribute

Detail

Founded

2005

Headquarters

Bernards, New Jersey

Employees

10,000-50,000

Revenue

$10B+ (estimated)

Certifications

ISO 14001 · ISO 45001

What Daiichi Sankyo, Inc makes

Daiichi Sankyo holds ISO 14001 and ISO 45001 certifications and maintains a clinical development pipeline in oncology supported by partnerships with AstraZeneca and other major pharmaceutical firms.

Certifications

Daiichi Sankyo, Inc is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

The company received 42 recorded shipments, predominantly sourced from Japan, with suppliers including Mr Go Saito (5 shipments) and multiple other Japanese partners, alongside imports from Singapore and the Republic of Korea. US customs bill-of-lading records list 42 inbound shipments across 37 foreign suppliers, with top origins including Singapore · Republic of Korea.

Latest developments

Company details

The company announced $1.9 billion in capital investment across production lines in China and the United States as of early 2026, and established a new Toronto headquarters to support oncology innovation and expansion in the Asia-Pacific region. Daiichi Sankyo, Inc was founded in 2005, has an estimated 10,000-50,000 employees, and is headquartered in Bernards, New Jersey. On the LightSource stability read it is rated "Established & active": 21 years in operation (founded 2005). 42 US import shipments on record. Holds ISO 14001, ISO 45001 certification(s) per public sources.

Frequently asked questions

What does Daiichi Sankyo, Inc do?

Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.

Where is Daiichi Sankyo, Inc headquartered?

Daiichi Sankyo, Inc is headquartered in Bernards, New Jersey (211 Mount Airy Road, Bernards, New Jersey, 07920).

When was Daiichi Sankyo, Inc founded?

Daiichi Sankyo, Inc was founded in 2005.

How big is Daiichi Sankyo, Inc?

Daiichi Sankyo, Inc has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).

What certifications does Daiichi Sankyo, Inc hold?

Daiichi Sankyo, Inc lists ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.

Does Daiichi Sankyo, Inc import from overseas suppliers?

US customs bill-of-lading records show 42 inbound shipments for Daiichi Sankyo, Inc, with top origins including Singapore · Republic of Korea.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Bernards, New Jersey (HQ)Headquarters · United States
Bernards, New Jersey (HQ)211 Mount Airy Road, Bernards, New Jersey, 07920, United StatesHeadquarters

Phone

'+1 973-944-2600

Certification

ISO 14001 · ISO 45001

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.